Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Journal of the American Heart Association|September 26, 2023
Development and Phenotype of Heart Failure in Long-Term Survivors of Childhood Cancer: The CVSS StudySebastian Göbel, Arthur Wingerter, Jürgen H Prochaska, et al.
Scientific Reports|December 29, 2019
Relation between platelet coagulant and vascular function, sex-specific analysis in adult survivors of childhood cancer compared to a population-based sampleMarina Panova-Noeva, Bianca Wagner, Markus Nagler, et al.
Pediatric Blood & Cancer|January 24, 2017
First experience of the AML-Berlin-Frankfurt-Münster group in pediatric patients with standard-risk acute promyelocytic leukemia treated with arsenic trioxide and all-trans retinoid acidUrsula Creutzig, Michael N Dworzak, Konrad Bochennek, et al.
Acta Ophthalmologica|January 23, 2025
Altered retinal vasculature in childhood cancer survivors: Data from the German CVSS-studyAlexander K Schuster, Anna Maria Voigt, Tamara Jäger, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 26, 2017
CD19 Isoforms Enabling Resistance to CART-19 Immunotherapy Are Expressed in B-ALL Patients at Initial DiagnosisJeannette Fischer, Claudia Paret, Khalifa El Malki, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 16, 2016
Pre-Emptive Immunotherapy for Clearance of Molecular Disease in Childhood Acute Lymphoblastic Leukemia after TransplantationEva Rettinger, Michael Merker, Emilia Salzmann-Manrique, et al.
Pediatric Blood & Cancer|September 21, 2022
Amsacrine combined with etoposide and methylprednisolone is a feasible and safe component in first-line intensified treatment of pediatric patients with high-risk acute lymphoblastic leukemia in CoALL08-09 trialKerstin Mezger, Sabine Ebert, Hannah Elisa Muhle, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 24, 2018
Cardiovascular risk factors are important determinants of platelet-dependent thrombin generation in adult survivors of childhood cancerMarina Panova-Noeva, Marie A Neu, Susan Eckerle, et al.
Nature Communications|February 14, 2025
The anti-GD2 monoclonal antibody naxitamab plus GM-CSF for relapsed or refractory high-risk neuroblastoma: a phase 2 clinical trialJaume Mora, Godfrey C F Chan, Daniel A Morgenstern, et al.
International Journal of Molecular Sciences|June 28, 2023
Glucosylceramide Synthase Inhibitors Induce Ceramide Accumulation and Sensitize H3K27 Mutant Diffuse Midline Glioma to IrradiationKhalifa El Malki, Pia Wehling, Francesca Alt, et al.
Pageof 9